Biocon

From Adani Group, Yes Bank, Biocon to Vedanta- Here are 8 stocks to watch

Stocks to watch today, September 19: GIFT Nifty indicates a lower start for domestic indices. Here are the top stocks…

September 19, 2025 06:29 IST

From Marico, Yes Bank, Waaree Energies to Biocon- Here are 10 stocks to watch

Stocks to watch today, September 18: GIFT Nifty indicates a higher start for domestic indices. Here are the top stocks…

September 18, 2025 06:29 IST

From NTPC, OLA Electric, Biocon to Varun Beverages- Here are 7 stocks to watch

Stocks to watch today, September 05: GIFT Nifty indicates a higher start for domestic indices. Here are the top stocks…

September 5, 2025 06:35 IST

From IndiGo, TCS to Oil India, BPCL – Here are 7 stocks in focus today

Track IndiGo, TCS, Oil India, BPCL, and more as major developments and investments put these 7 stocks in focus- see…

August 28, 2025 06:26 IST

National Manufacturing Mission, biotechnology, DII, Sai Life Sciences, Biocon

Alert: Why DIIs are doubling down on these 2 biotech companies

India’s biotech industry is projected to more than double to US$ 300B by 2030. And the ‘smart money’ is making…

August 9, 2025 05:20 IST

Siddaramaiah vs Biocon's Kiran Mazumdar-Shaw

Siddaramaiah vs Biocon: Covid vaccine-death fear debate intensifies, ‘scientific caution is not anti-science’

Karnataka CM Siddaramaiah and Biocon chief Kiran Mazumdar-Shaw have been up in arms against each other over the heated debate…

July 4, 2025 09:26 IST

Biocon Biologics secures EU nod for two Denosumab biosimilars, expanding bone health treatment access in Europe.

Biocon Biologics gets EU approval for 2 drugs to treat bone cancer, osteoporosis and bone loss

Biocon Biologics, a subsidiary of Biocon, has secured EU marketing authorisation for its Denosumab biosimilars Vevzuo and Evfraxy, expanding treatment…

July 3, 2025 11:08 IST

India’s Biocon eyes Canadian weight-loss market with cheaper Ozempic, Wegovy alternatives by 2026

The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other emerging markets, Bloomberg…

Updated: July 2, 2025 10:32 IST

Biocon Biologics gets nod to launch eye medicine, Yesafili in Canada

Biocon Biologics secures Health Canada approval for Yesafili, the first biosimilar to Eylea® in Canada, with a global launch scheduled…

June 27, 2025 11:25 IST

Biocon Biologics and NCSM officials signing MoU to launch cancer care program in Malaysia. (Image: Canva)

Biocon Biologics partners Malaysia’s top cancer NGO for affordable cancer drugs

Biocon Biologics collaborates with Malaysia’s National Cancer Society to launch a Patient Assistance Program, providing affordable biosimilars like Trastuzumab to…

June 24, 2025 12:05 IST

Stocks to watch today: From HDFC Bank, Nestle India to HCL Tech – Here are 10 stocks in focus

Discover 10 key stocks to watch today, including HDFC Bank’s IPO and Nestle India’s bonus issue. Check updates to inform…

June 20, 2025 06:22 IST

From Asian Paints, Reliance Industries, TCS to Biocon – Here are 8 stocks to watch

Stocks to watch today, June 17: GIFT Nifty indicates a flat start for domestic indices. Here are top stocks to…

June 17, 2025 06:35 IST

stocks to watch, stock in news, stocks in news, stocks to know

Stocks to watch today: From Grasim Industries, HCL Tech to Biocon – Here are 7 stocks in focus today

Watch top stocks today: Grasim, HCL, Biocon and more as they make key moves and announcements. Explore the detailed insights…

June 3, 2025 06:39 IST

indian pharma stock price, pharmacueticals

Will Indian pharma withstand the Trump administration?

Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to grow…

May 14, 2025 05:30 IST

Kiran Mazumdar-Shaw discusses the impact of US drug price reduction efforts on Indian pharma. (Image Source: Twitter)

Trump’s drug pricing order boosts case for generics and biosimilars: Kiran Mazumdar-Shaw

Kiran Mazumdar-Shaw discusses the impact of US drug price reduction efforts on Indian pharma, Biocon’s US expansion, strong Q4 generics…

May 13, 2025 19:27 IST

Protean eGov Technologies share price, PAN 2.0 project

Syngene International shares plummet 13%: Here’s what’s worrying investors

Syngene share price today, April 24: Syngene’s stock drops 13% due to 8% Q4 profit decline. Explore insights into their…

April 24, 2025 14:22 IST

Tariff Panic! 3 crucial concerns as pharma stocks plunge on Trump’s big claims

Pharma stocks drop as Trump announces major tariffs on imports. Explore market impact!

April 9, 2025 12:29 IST

Trump tariff, pharma stocks surge, Nifty Pharma Index, US-India trade,

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

Pharma stocks surge as Trump’s tariff exemption boosts sector morale. Dive into this bullish trend today!

April 3, 2025 10:45 IST

Related News

Green card holders, 2025 Naturalization Civics Test full list, 2025 civics test, U.S. citizenship, naturalization process, US immigration policy, new naturalization civics test 2025, USCIS 2025 citizenship test

US announces 2025 civics test for green card holders starting today

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Harsh Goenka slams DK Shivakumar over Kiran Mazumdar-Shaw’s Bengaluru infrastructure comments.

Bengaluru infrastructure row: Harsh Goenka slams Shivakumar after criticism of Kiran Mazumdar-Shaw, says ‘It’s unfortunate how…’

Business tycoon Anand Mahindra shared a serene glimpse of Palakkad, Kerala, calling it “the perfect escape” from modern life’s chaos.

‘Not a tourist destination, nor…’: Anand Mahindra calls Kerala’s Palakkad village ‘the perfect escape’ from modern life

Mappls vs Google Maps: 5 standout features of India’s homegrown navigation app

Stressed by H-1B process, Indian-origin techie is using AI to simplify work-visa filing

Business13 min ago

America’s visa system is notoriously complex, and Priyanka Kulkarni knows it better than most. The 34-year-old machine learning scientist spent nine years juggling the visa process herself. Now, she’s using artificial intelligence to help others handle work-based immigration smoothly and hassle-free.

View all shorts